MMW Fortschritte der Medizin

National Disease Management Guideline Type 2 Diabetes. Part 1: Pharmacotherapy of glucose metabolism plus shared decision making and participation in all relevant areas of life

2021Regional

Europe

Original at the sourceAsk Osler about this guideline

Source and rights

Published by MMW Fortschritte der Medizin, 2021. The guideline itself is at the source linked here.

Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.

At a glance

Published: 2021
Applies to: 🇪🇺 Europe
Scope: Regional
Journal: MMW Fortschritte der Medizin
DOI: 10.1007/s15006-021-9814-x
PubMed: 33904092
Added to Prognia: 23 July 2026

Ask a question about this guideline.

Osler answers from this library and names the guideline behind every claim.

Discover Osler

Who and how to screen for Cushing's syndrome: the position statement of the Italian Society of EndocrinologyWorld Health Organization · 2026Added 23 Jul 2026

Diabetes technology (Update 2026)Wiener klinische Wochenschrift · 2026Added 23 Jul 2026PDF

ISPAD Position Statement on Type 1 Diabetes in SchoolsInternational Society for Pediatric and Adolescent Diabetes · 2026Added 18 Jul 2026PDF

SICOB Italian Clinical Practice GRADE-based guidelines for the endobariatric treatment of overweight, obesity, and obesity-associated diseasesUpdates in surgery · 2026Added 18 Jul 2026PDF

Part 2: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Risk Stratifying Patients With MASLD.Dysfunction-Associated Steatotic Liver Disease Working Group · 2026Added 18 Jul 2026PDF

Part 3: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Ultrasound Shear Wave Elastography and MR Elastography Program Implementation, Funding, and Quality AssuranceDysfunction-Associated Steatotic Liver Disease Working Group · 2026Added 18 Jul 2026PDF

Part 1: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Guidance Statements for Detecting and Grading Hepatic Steatosis Using Ultrasound, CT, or MRI.Dysfunction-Associated Steatotic Liver Disease Working Group · 2026Added 18 Jul 2026PDF

Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025Endocrine Society · 2026Added 18 Jul 2026PDF

European Association for the Study of Obesity Position Statement on the Diagnosis and Management of Obesity in Older AdultsObesity facts · 2026Added 18 Jul 2026PDF

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026American Diabetes Association · 2026Added 18 Jul 2026PDF